Neuronetics (STIM) CEO sells 8,452 shares to cover RSU tax

Rhea-AI Filing Summary

Neuronetics, Inc. President and CEO Keith J. Sullivan reported an open-market sale of 8,452 shares of common stock at a reported weighted average price of $1.35 per share. According to the filing, these were non-discretionary sales to satisfy tax withholding obligations upon vesting of a restricted stock unit award. After the transaction, Sullivan directly owned 1,524,713 shares of Neuronetics common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sullivan Keith J

(Last) (First) (Middle)

C/O NEURONETICS, INC.

3222 PHOENIXVILLE PIKE

(Street)

MALVERN PA 19355

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		S		8,452(1)	D	$1.35(2)	1,524,713	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Patrick Devine, as Attorney-in-Fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Neuronetics (STIM) CEO Keith Sullivan report in this Form 4 filing?

Keith J. Sullivan reported selling 8,452 Neuronetics common shares. The sale was described as non-discretionary and executed to cover tax withholding upon vesting of a restricted stock unit award, and he continued to hold 1,524,713 shares afterward.

How many Neuronetics (STIM) shares did the CEO sell and at what price?

The CEO sold 8,452 shares of Neuronetics common stock at a reported weighted average price of $1.35 per share. A footnote explains trades occurred between $1.38 and $1.31 per share across multiple transactions that day.

Why were Neuronetics (STIM) shares sold in this Keith Sullivan Form 4?

The Form 4 states the sales were non-discretionary to satisfy Keith Sullivan’s tax withholding obligation. This obligation arose when a portion of a restricted stock unit award vested, prompting automatic share sales rather than a voluntary portfolio decision.

How many Neuronetics (STIM) shares does Keith Sullivan own after the reported sale?

Following the reported tax-related sale, Keith Sullivan directly owned 1,524,713 shares of Neuronetics common stock. This figure reflects his remaining direct holdings after the 8,452 shares were sold to cover the vesting-related tax withholding obligation.

Was the Neuronetics (STIM) CEO’s share sale an open-market transaction?

Yes, the filing classifies the transaction as an open-market sale of common stock. However, the accompanying footnote clarifies the sales were non-discretionary and executed specifically to cover tax withholding from a vesting restricted stock unit award.